The “Bifidobacterium breve” is an intestinal probiotic that can produce trans-9, trans-11 conjugated linoleic acid (CLA) from free linoleic acid. The probiotic “Bifidobacteria” species are the resident organisms that produce acids that retard the colonization of certain foreign or harmful bacteria in the colon. •
Bifidobacterium breve is beneficial for the treatment of inflammatory bowel disease, prevents rotavirus-induced diarrhea and activates the humoral immune system. Bifidobacterium breve survives in stomach acid. Supports the digestive system; blocks growth of harmful bacteria; boosts immune system; digests over 20 carbohydrates; produces a natural antibiotic & lactic acid; helps absorb cancer causing carcinogenics, especially those produced by charred meats.
In Studies: Bifidobacterium breve alleviated both allergic and autoimmune responses. Bifidobacterium breve has a positive effect on the immune system, in contrast to the moderate Lactobacillus casei Shirota response. - 2006 Netherlands
The statements on this Web site have not been evaluated by the Food and Drug Administration (FDA). And are not intended to diagnose, treat, cure or prevent disease. The information presented is not intended to replace medical advice or treatment from your own doctor or healthcare provider. Nothing presented here is intended as a substitute for prescription medication or any other medical treatment prescribed by your doctor.